HealthQuill Talzenna
Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug to treat neurodegenerative disease, amyotrophic lateral sclerosis.
Drugs Health Pharma

UK approves oral pill to treat advanced prostate cancer

HQ Team July 19, 2024: A new pill that treats hormone sensitive advance prostate cancer has been approved by the National Institute for.

Read More
The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer in adult patients, according to a statement.
Drugs Health Pharma

Pfizer gets FDA nod for combination drug to treat advanced prostate cancer

HQ Team June 21, 2023: The USFDA has approved Pfizer Inc’s oral Talzenna drug in combination with Xtandi to treat advanced prostate cancer.

Read More